This Article Figures Only Full Text Full Text (PDF) View Online Appendix Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Westerhout, C. M. Search for Related Content PubMed PubMed Citation Articles by Westerhout, C. M.

CLINICAL RESEARCH: ACUTE CORONARY SYNDROME

Short- and Long-Term Risk Stratification in Acute Coronary Syndromes

The Added Value of Quantitative ST-Segment Depression and Multiple Biomarkers

Cynthia M. Westerhout, MSc^_*,,_*, Yuling Fu, MD^_*, Michael S. Lauer, MD, FACC, Stefan James, MD, PhD, Paul W. Armstrong, MD, FACC^_*, Eyad Al-Hattab, MD, Robert M. Califf, MD, FACC^||,2, Maarten L. Simoons, MD, FACC, Lars Wallentin, MD, PhD, FACC^,1, Eric Boersma, PhD on behalf of the GUSTO-IV ACS Trial Investigators

^_* University of Alberta, Edmonton, Canada
Erasmus Medical Center, Rotterdam, the Netherlands
Cleveland Clinic Foundation, Cleveland, Ohio
University of Uppsala, Uppsala, Sweden
^|| Duke Clinical Research Institute, Durham, North Carolina

Manuscript received January 1, 2006; revised manuscript received March 28, 2006, accepted April 24, 2006.

^_* Reprint requests and correspondence: Ms. Cynthia M. Westerhout, 214 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, T6G 2S2 Canada. (Email: cindy.westerhout{at}ualberta.ca).

OBJECTIVES: The purpose of this study was to develop 30-day and 1-year risk stratification models for non–ST-segment elevation acute coronary syndrome (NSTE-ACS) patients that incorporate quantitative ST-segment depression and novel biomarkers.

BACKGROUND: Several novel biomarkers have changed the risk profile of ACS; thus, the reassessment of traditional indicators such as ST-segment depression in this new context is warranted.

METHODS: Multivariable logistic regression was used to identify significant predictors of 30-day death and death/myocardial infarction (MI) and 1-year mortality in 7,800 NSTE-ACS patients enrolled in the GUSTO-IV (Global Utilization of Strategies to Open Occluded Arteries-IV ACS) trial between 1998 and 2000.

RESULTS: Among all other predictors, the degree of ST-segment depression had the highest prognostic value for 30-day death, 30-day death/MI, and 1-year death. Troponin T (TnT), creatinine clearance, N-terminal pro-brain natriuretic peptide (NT-proBNP), heart rate, and age were also highly influential on adverse outcomes. Unlike TnT and NT-proBNP, C-reactive protein was only predictive of long-term death. In contrast to mortality, the contribution of TnT to predicting 30-day death/MI increased, whereas NT-proBNP’s role was attenuated. The discriminatory power was excellent (c-index [adjusted for over-optimism]: 0.82 [30-day death]; 0.72 [30-day death/MI]; 0.81 [1-year]).

CONCLUSIONS: In this large contemporary study of NSTE-ACS patients, novel insights into risk stratification were observed—in particular, the utility of quantitative ST-segment depression and multiple biomarkers. Collection of these indicators in future NSTE-ACS populations is recommended to evaluate generalizability and clinical application of these findings.

Abbreviations and Acronyms   CRP = C-reactive protein   ECG = electrocardiogram   NSTE-ACS = non–ST-segment elevation acute coronary syndrome   NT-proBNP = N-terminal pro-brain natriuretic peptide   PCI = percutaneous coronary intervention   TnT = cardiac troponin T

This article has been cited by other articles:

				K. M. Eggers, B. Lagerqvist, P. Venge, L. Wallentin, and B. Lindahl Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. J. Am. Coll. Cardiol., July 21, 2009; 54(4): 357 - 364. [Abstract] [Full Text] [PDF]

				C. R. deFilippi and S. L. Seliger Biomarkers for prognostication after acute coronary syndromes: new times and statistics. J. Am. Coll. Cardiol., July 21, 2009; 54(4): 365 - 367. [Full Text] [PDF]

				K. M. Eggers, T. Kempf, T. Allhoff, B. Lindahl, L. Wallentin, and K. C. Wollert Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain Eur. Heart J., October 1, 2008; 29(19): 2327 - 2335. [Abstract] [Full Text] [PDF]

				L. B. Daniels, G. A. Laughlin, P. Clopton, A. S. Maisel, and E. Barrett-Connor Minimally Elevated Cardiac Troponin T and Elevated N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality in Older Adults: Results From the Rancho Bernardo Study J. Am. Coll. Cardiol., August 5, 2008; 52(6): 450 - 459. [Abstract] [Full Text] [PDF]

				R. P. Giugliano and E. Braunwald The Year in Non ST-Segment Elevation Acute Coronary Syndrome J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1386 - 1395. [Full Text] [PDF]

				C. M. Westerhout, M. S. Lauer, S. James, Y. Fu, L. Wallentin, P. W. Armstrong, and for the GUSTO IV ACS Investigators Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women Eur. Heart J., September 1, 2007; 28(17): 2064 - 2069. [Abstract] [Full Text] [PDF]